SYNOVUS FINANCIAL CORP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,018,744
-21.1%
40,198
-0.7%
0.02%
-17.9%
Q2 2023$2,558,396
+31.9%
40,481
-6.1%
0.03%
+27.3%
Q1 2023$1,939,654
-7.4%
43,113
-9.8%
0.02%
-8.3%
Q4 2022$2,095,126
-7.4%
47,823
+39.2%
0.02%
-14.3%
Q3 2022$2,262,000
+51.8%
34,357
+16.3%
0.03%
+64.7%
Q2 2022$1,490,000
-12.5%
29,549
+10.6%
0.02%
-5.6%
Q1 2022$1,703,000
-25.7%
26,723
+24.8%
0.02%
-21.7%
Q4 2021$2,293,000
+5.5%
21,405
+1.0%
0.02%0.0%
Q3 2021$2,174,000
+63.7%
21,186
+40.2%
0.02%
+76.9%
Q2 2021$1,328,000
-4.6%
15,112
+5.5%
0.01%
-18.8%
Q1 2021$1,392,000
+27740.0%
14,322
+22633.3%
0.02%
Q2 2020$5,000
+25.0%
630.0%0.00%
Q1 2020$4,000
-20.0%
630.0%0.00%
Q4 2019$5,0000.0%630.0%0.00%
Q3 2019$5,000
-16.7%
630.0%0.00%
Q2 2019$6,000
+20.0%
630.0%0.00%
Q1 2019$5,000
+66.7%
630.0%0.00%
Q4 2018$3,000
-40.0%
630.0%0.00%
Q3 2018$5,000630.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders